Please Wait.....
Report
Bilirubin Meters Market? By Product (Bench-Top, Transcutaneous) , By Indication (Jaundice, Hepatitis) By Age Group (Neonatal, Adults) By End User (Hospitals and Nursing Home, Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.
The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.
The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the transcutaneous segment dominated the market share in 2023.
On the basis of indication, the jaundice segment was the major shareholder in 2023.
As per age group, neonatal emerged as the leading segment in 2023.
Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.
Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
By Product
- Bench-Top
- Transcutaneous
By Indication
- Jaundice
- Hepatitis
By Age Group
- Neonatal
- Adults
By End User
- Hospitals and Nursing Home
- Clinics
- Others
- Key Market Players
- APEL Co. Ltd
- Dragerwerk AG & Co. KGaA
- Mennen Medical Ltd
- Micro Lab Instruments
- Ningbo David Medical Device Co. Ltd
- Siemens Healthineers AG
- Micro Labs Instruments
- AVI Healthcare Pvt Ltd
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CARDIAC MONITORING PRODUCTS MARKET, BY DEVICE TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Device Type
4.2. ECG Monitor
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Event Recorder
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Implantable Cardiac Loop Recorder
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Pacemaker
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Defibrillator
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Cardiac Resynchronization Therapy (CRT) Devices
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Smart Wearable
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
4.9. Other
4.9.1. Key Market Trends, Growth Factors and Opportunities
4.9.2. Market Size and Forecast, By Region
4.9.3. Market Share Analysis, By Country
CHAPTER 5: CARDIAC MONITORING PRODUCTS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Specialty Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Ambulatory Care
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Homecare
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Other
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: CARDIAC MONITORING PRODUCTS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Device Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Cardiac Monitoring Products Market
6.2.5.1. Market Size and Forecast, By Device Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Cardiac Monitoring Products Market
6.2.6.1. Market Size and Forecast, By Device Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Cardiac Monitoring Products Market
6.2.7.1. Market Size and Forecast, By Device Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Device Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Cardiac Monitoring Products Market
6.3.5.1. Market Size and Forecast, By Device Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Cardiac Monitoring Products Market
6.3.6.1. Market Size and Forecast, By Device Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Cardiac Monitoring Products Market
6.3.7.1. Market Size and Forecast, By Device Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Cardiac Monitoring Products Market
6.3.8.1. Market Size and Forecast, By Device Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Cardiac Monitoring Products Market
6.3.9.1. Market Size and Forecast, By Device Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Cardiac Monitoring Products Market
6.3.10.1. Market Size and Forecast, By Device Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Device Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Cardiac Monitoring Products Market
6.4.5.1. Market Size and Forecast, By Device Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Cardiac Monitoring Products Market
6.4.6.1. Market Size and Forecast, By Device Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Cardiac Monitoring Products Market
6.4.7.1. Market Size and Forecast, By Device Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Cardiac Monitoring Products Market
6.4.8.1. Market Size and Forecast, By Device Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Cardiac Monitoring Products Market
6.4.9.1. Market Size and Forecast, By Device Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Cardiac Monitoring Products Market
6.4.10.1. Market Size and Forecast, By Device Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Device Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Cardiac Monitoring Products Market
6.5.5.1. Market Size and Forecast, By Device Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Cardiac Monitoring Products Market
6.5.6.1. Market Size and Forecast, By Device Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Cardiac Monitoring Products Market
6.5.7.1. Market Size and Forecast, By Device Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Cardiac Monitoring Products Market
6.5.8.1. Market Size and Forecast, By Device Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Medtronic Plc
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Boston Scientific Corporation
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. GE Healthcare
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. IRhythm Technologies Inc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Biotronik
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. LivaNova PLC
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Baxter International Inc.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Schiller AG
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Koninklijke Philips N.V.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. BILIRUBIN METERS MARKET FOR BENCH-TOP, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. BILIRUBIN METERS MARKET FOR TRANSCUTANEOUS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 5. BILIRUBIN METERS MARKET FOR JAUNDICE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. BILIRUBIN METERS MARKET FOR HEPATITIS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 8. BILIRUBIN METERS MARKET FOR NEONATAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. BILIRUBIN METERS MARKET FOR ADULTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. GLOBAL BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 11. BILIRUBIN METERS MARKET FOR HOSPITALS AND NURSING HOME, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. BILIRUBIN METERS MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. BILIRUBIN METERS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. BILIRUBIN METERS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA BILIRUBIN METERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 18. NORTH AMERICA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. U.S. BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 21. U.S. BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 22. U.S. BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 23. U.S. BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. CANADA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 25. CANADA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 26. CANADA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 27. CANADA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. MEXICO BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 29. MEXICO BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 30. MEXICO BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 31. MEXICO BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. EUROPE BILIRUBIN METERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 33. EUROPE BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. EUROPE BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 35. EUROPE BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 36. EUROPE BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. GERMANY BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 38. GERMANY BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 39. GERMANY BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 40. GERMANY BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. FRANCE BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 42. FRANCE BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 43. FRANCE BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 44. FRANCE BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. UK BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. UK BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 47. UK BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 48. UK BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. ITALY BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 50. ITALY BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 51. ITALY BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 52. ITALY BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. SPAIN BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 54. SPAIN BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 55. SPAIN BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 56. SPAIN BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. REST OF EUROPE BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 58. REST OF EUROPE BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 59. REST OF EUROPE BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 60. REST OF EUROPE BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. ASIA-PACIFIC BILIRUBIN METERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 62. ASIA-PACIFIC BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 63. ASIA-PACIFIC BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 64. ASIA-PACIFIC BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 65. ASIA-PACIFIC BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 66. JAPAN BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 67. JAPAN BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 68. JAPAN BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 69. JAPAN BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. CHINA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 71. CHINA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 72. CHINA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 73. CHINA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. AUSTRALIA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. AUSTRALIA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 76. AUSTRALIA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 77. AUSTRALIA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. INDIA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 79. INDIA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 80. INDIA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 81. INDIA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH KOREA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH KOREA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 84. SOUTH KOREA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 85. SOUTH KOREA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. REST OF ASIA-PACIFIC BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 87. REST OF ASIA-PACIFIC BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 88. REST OF ASIA-PACIFIC BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 89. REST OF ASIA-PACIFIC BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 90. LAMEA BILIRUBIN METERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 91. LAMEA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 92. LAMEA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 93. LAMEA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 94. LAMEA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 95. BRAZIL BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 96. BRAZIL BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 97. BRAZIL BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 98. BRAZIL BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 99. SAUDI ARABIA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 100. SAUDI ARABIA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 101. SAUDI ARABIA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 102. SAUDI ARABIA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 103. SOUTH AFRICA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 104. SOUTH AFRICA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 105. SOUTH AFRICA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 106. SOUTH AFRICA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 107. REST OF LAMEA BILIRUBIN METERS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 108. REST OF LAMEA BILIRUBIN METERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
TABLE 109. REST OF LAMEA BILIRUBIN METERS MARKET, BY AGE GROUP, 2024 - 2033 ($BILLION)
TABLE 110. REST OF LAMEA BILIRUBIN METERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 111. APEL CO. LTD: KEY EXECUTIVES
TABLE 112. APEL CO. LTD: COMPANY SNAPSHOT
TABLE 113. APEL CO. LTD: OPERATING SEGMENTS
TABLE 114. APEL CO. LTD: PRODUCT PORTFOLIO
TABLE 115. APEL CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. DRAGERWERK AG AND CO. KGAA: KEY EXECUTIVES
TABLE 117. DRAGERWERK AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 118. DRAGERWERK AG AND CO. KGAA: OPERATING SEGMENTS
TABLE 119. DRAGERWERK AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 120. DRAGERWERK AG AND CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. MENNEN MEDICAL LTD: KEY EXECUTIVES
TABLE 122. MENNEN MEDICAL LTD: COMPANY SNAPSHOT
TABLE 123. MENNEN MEDICAL LTD: OPERATING SEGMENTS
TABLE 124. MENNEN MEDICAL LTD: PRODUCT PORTFOLIO
TABLE 125. MENNEN MEDICAL LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. MICRO LAB INSTRUMENTS: KEY EXECUTIVES
TABLE 127. MICRO LAB INSTRUMENTS: COMPANY SNAPSHOT
TABLE 128. MICRO LAB INSTRUMENTS: OPERATING SEGMENTS
TABLE 129. MICRO LAB INSTRUMENTS: PRODUCT PORTFOLIO
TABLE 130. MICRO LAB INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY EXECUTIVES
TABLE 132. NINGBO DAVID MEDICAL DEVICE CO. LTD: COMPANY SNAPSHOT
TABLE 133. NINGBO DAVID MEDICAL DEVICE CO. LTD: OPERATING SEGMENTS
TABLE 134. NINGBO DAVID MEDICAL DEVICE CO. LTD: PRODUCT PORTFOLIO
TABLE 135. NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136. SIEMENS HEALTHINEERS AG: KEY EXECUTIVES
TABLE 137. SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
TABLE 138. SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
TABLE 139. SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
TABLE 140. SIEMENS HEALTHINEERS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 141. MICRO LABS INSTRUMENTS: KEY EXECUTIVES
TABLE 142. MICRO LABS INSTRUMENTS: COMPANY SNAPSHOT
TABLE 143. MICRO LABS INSTRUMENTS: OPERATING SEGMENTS
TABLE 144. MICRO LABS INSTRUMENTS: PRODUCT PORTFOLIO
TABLE 145. MICRO LABS INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 146. AVI HEALTHCARE PVT LTD: KEY EXECUTIVES
TABLE 147. AVI HEALTHCARE PVT LTD: COMPANY SNAPSHOT
TABLE 148. AVI HEALTHCARE PVT LTD: OPERATING SEGMENTS
TABLE 149. AVI HEALTHCARE PVT LTD: PRODUCT PORTFOLIO
TABLE 150. AVI HEALTHCARE PVT LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 152. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 153. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 154. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 155. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 156. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 157. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 158. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 159. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 160. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL BILIRUBIN METERS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF BILIRUBIN METERS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN BILIRUBIN METERS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBILIRUBIN METERS MARKET
FIGURE 10. GLOBAL BILIRUBIN METERS MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. BILIRUBIN METERS MARKET FOR BENCH-TOP, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. BILIRUBIN METERS MARKET FOR TRANSCUTANEOUS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL BILIRUBIN METERS MARKET SEGMENTATION, BY INDICATION
FIGURE 14. BILIRUBIN METERS MARKET FOR JAUNDICE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. BILIRUBIN METERS MARKET FOR HEPATITIS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL BILIRUBIN METERS MARKET SEGMENTATION, BY AGE GROUP
FIGURE 17. BILIRUBIN METERS MARKET FOR NEONATAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. BILIRUBIN METERS MARKET FOR ADULTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. GLOBAL BILIRUBIN METERS MARKET SEGMENTATION, BY END USER
FIGURE 20. BILIRUBIN METERS MARKET FOR HOSPITALS AND NURSING HOME, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. BILIRUBIN METERS MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. BILIRUBIN METERS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 27. COMPETITIVE DASHBOARD
FIGURE 28. COMPETITIVE HEATMAP: BILIRUBIN METERS MARKET
FIGURE 29. TOP PLAYER POSITIONING, 2023
FIGURE 30. APEL CO. LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. APEL CO. LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. APEL CO. LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. DRAGERWERK AG AND CO. KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. DRAGERWERK AG AND CO. KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. DRAGERWERK AG AND CO. KGAA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. MENNEN MEDICAL LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. MENNEN MEDICAL LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. MENNEN MEDICAL LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MICRO LAB INSTRUMENTS: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MICRO LAB INSTRUMENTS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MICRO LAB INSTRUMENTS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. NINGBO DAVID MEDICAL DEVICE CO. LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. SIEMENS HEALTHINEERS AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. MICRO LABS INSTRUMENTS: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. MICRO LABS INSTRUMENTS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. MICRO LABS INSTRUMENTS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. AVI HEALTHCARE PVT LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. AVI HEALTHCARE PVT LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. AVI HEALTHCARE PVT LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 58. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security